Laboratorial evaluation and diagnosis of insulin resistance;Avaliação laboratorial e diagnóstico da resistência insulínica

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 50, Issue 2, 2006, Pages 208-215

  Geloneze, Bruno ^a   Tambascia, Marcos Antonio ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Glucose tolerance oral test; HOMA; Insulin resistance; Insulin suppression test; QUICKI

Indexed keywords

INSULIN;

BLOOD; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; METABOLIC SYNDROME X;

EID: 33744494568     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302006000200007     Document Type: Review

References (44)

1. Reaven GM. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
2. DeFronzo RA. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1992;35:389-97.
3. Yki-Järvinen H, Koivisto VA. Natural course of insulin resistance in type 1 diabetes. N Engl J Med 1986;315:224-30.
4. Luzi L, Barret EJ, Groop LC, Ferranini E, DeFronzo RA. Metabolic effects of low dose insulin therapy in glucose metabolism in diabetic ketacidosis. Diabetes 1988;37:1470-7.
5. Bonadonna R, Groop L, Kraemer N, Ferranini E, Del Prato S, DeFronzo R. Obesity and insulin resistance in humans: A dose response study. Metabolism 1990;39:452-9.
6. Kissebah AH. Insulin resistance in visceral obesity. Int J Obes 1991;15:109-15.
7. DeFronzo RA. Glucose intolerance and aging: Evidence for tissue insensitivity to insulin. Diabetes 1979;28:1095-101.
8. DeFronzo RA, Ferranini E. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
9. Ferranini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: The key feature of cardiovascular and metabolic syndrome. Diabetologia 1991;34:416-22.
10. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyorala K, Salonen JT, et al. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb 1991;11:1068-76.
11. Saad M, Anderson R, Laws A, Watanabe R, Kades W, Chen Y-D, et al. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance: For the insulin resistance atherosclerosis study. Diabetes 1994;43:1114-21.
12. Levine R. Diabetes: The pancreas and insulin, retrospective view. Can J Biochem 1979;57:447-54.
13. Levine R. The endocrine pancreas, past and present. Adv Exp Med Biol 1979;124:1-13.
14. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocrine Rev 1985;6:45-85.
15. Yalow RS, Berson SA. Immunoassay of endogenous plasma insulin in men. 1960. Obes Res 1996;4:583-600.
16. Olefsky JM, Farquhar JW, Reaven GM. Relationship between fasting plasma insulin level and insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes 1973;22:507-13.
17. Hollenbeck CB, Chen N, Chen Y-DI, Reaven GM. Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 1984;33:460-3.
18. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D. Disproportionate elevation of immunoreactive pro-insulin in type 2 (non-insulin dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 1987;30:698-702.
19. Turner R, Holman RR, Matthews D, Hockaday TR, Peto J. Insulin deficiency and insulin resistance interaction in diabetes: Estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentration in man. Metabolism 1979;28:1086-96.
20. Matthews D, Hosker JP, Rudenski AS, Naylor BA, Trecher DF, Turner RC. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-9.
21. Pereira JA, Lazarin MACT, Carvalho OMF, Pareja JC, Geloneze B, Chain EA, et al. Evaluation of insulin sensitivity in morbid obese patients due to euglycemic hyperinsulinemic clamp. Arq Bras Endocrinol Metab 1999;43(suppl. 2):S60.
22. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000;23:57-63.
23. Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN. The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 2005;[in press].
24. DeFronzo RA. Lilly lecture. The triumvirate: Beta cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-87.
25. Bergman RN. Lilly lecture. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 1989;38:1512-27.
26. Finegood DT, Hramiak IM, Dupre J. A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 1990;70:1538-49.
27. Steil GM, Volund A, Kahn SE, Bergman RN. Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model: Suitability for use in population studies. Diabetes 1993;42:250-6.
28. Cobelli C, Pacini G, Toffolo G, Sacca L. Estimation of insulin sensitivity and glucose clearence from minimal model: New insights from labeled IVGTT. Am J Physiol 1986;250:E591-8.
29. Davis SN, Monti L, Piatti PM, Moller N, Ng L, Coppack S, et al. Estimates of insulin action in normal, obese and NIDDM man: Comparison of insulin and glucose infusion test, CIGMA, minimal model and glucose clamp techniques. Diabetes Res Clin Pract 1993;23:1-18.
30. Foley JE, Chen YD, Lardinois CK, Hollenbeck CB, Liu GC, Reaven GM. Estimates of in vivo insulin action in humans: Comparison of the insulin clamp and the minimal model techniques. Horm Metabol Res 1985;17:406-9.
31. Katz A, Nambi SS, Mather K. Quantitative Insulin Sensitivity Check Index (QUICKI): A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10.
32. Chen H, Sullivan G, Quon MJ. Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 2005;54:1914-25.
33. Rizza RA, Cryer PE, Gerich JE. Role of glucagon, cathecolamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alfa and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. J Clin Invest 1979;64:591.
34. Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, et al. Estimates of in vivo insulin action in man: Comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 1989;68:374-8.
35. Geloneze B, Rodovalho-Geloneze S, Parisi C, Pícolo M, Repetto EM, Tambascia MA. Standardization of insulin tolerance test (ITT) in Brazilian population. Diabetes Res Clin Pract 2000;50(suppl. 1):S102.
36. Geloneze B, Tambascia MA, Pareja JC, Repetto EM, Magna LA. The insulin tolerance test in severely obese patients undergoing bariatric surgery. Obes Res 2001;9:763-9.
37. Shen SW, Reaven GM, Farquhar JW. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 1970;49:2151-60.
38. DeFronzo R, Ferranini E, Hendler R, Felig P, Wharen J. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 1983;32:35-45.
39. DeFronzo RA, Binder C, Wahren J, Felig P, Ferranini E, Faber OK. Sensitivity of insulin secretion to feedback inhibition by hyperinsulinemia. Acta Endocrinol 1981;93:81-6.
40. Reaven GM, Olefsky JM. Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes. Diabetologia 1977;13:201-6.
41. Harano Y, Ohgaku S, Hidaka H, Haneda K, Kikkawa R, Shigeta Y, et al. Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. J Clin Endocrinol Metab 1977;45:1124-7.
42. Ratzman KP, Besch W, Witt S, Shulz B. Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance. Diabetologia 1981;21:192-7.
43. DeFronzo R, Tobin J, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
44. American Diabetes Association. Conference development on insulin resistance. Diabetes Care 1998;21:310-4.